EA201791409A1 - Препараты для инъекций парацетамола - Google Patents

Препараты для инъекций парацетамола

Info

Publication number
EA201791409A1
EA201791409A1 EA201791409A EA201791409A EA201791409A1 EA 201791409 A1 EA201791409 A1 EA 201791409A1 EA 201791409 A EA201791409 A EA 201791409A EA 201791409 A EA201791409 A EA 201791409A EA 201791409 A1 EA201791409 A1 EA 201791409A1
Authority
EA
Eurasian Patent Office
Prior art keywords
preparations
paracetamol
intravenous
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
EA201791409A
Other languages
English (en)
Inventor
Кетан Р. Пател
Милан Р. Пател
Ашил К. Пател
Пакашчандра Дж. Шах
Original Assignee
Троикаа Фармасьютикалз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55022620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201791409(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Троикаа Фармасьютикалз Лимитед filed Critical Троикаа Фармасьютикалз Лимитед
Publication of EA201791409A1 publication Critical patent/EA201791409A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к препаратам для внутривенных инъекций парацетамола или его фармацевтически приемлемой соли с низким объемом или и к способу их приготовления. Препараты обеспечивают высокую концентрацию парацетамола или его фармацевтически приемлемой соли в системе растворителей по настоящему изобретению, они могут вводиться не только способом внутримышечного и внутривенного вливания, но они также пригодны для медленного внутривенного введения болюса после разбавления жидкостями на водной основе до конечного объема не больше 20 мл. Эти препараты для инъекций остаются стабильными и являются также пригодными для введения медленным внутривенным способом при доведении до минимума побочных воздействий (таких как флебит, боль и т.п.).
EA201791409A 2014-12-20 2015-11-17 Препараты для инъекций парацетамола EA201791409A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4102MU2014 2014-12-20
PCT/IB2015/058876 WO2016097899A1 (en) 2014-12-20 2015-11-17 Injectable formulations of paracetamol

Publications (1)

Publication Number Publication Date
EA201791409A1 true EA201791409A1 (ru) 2017-10-31

Family

ID=55022620

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791409A EA201791409A1 (ru) 2014-12-20 2015-11-17 Препараты для инъекций парацетамола

Country Status (28)

Country Link
US (1) US20180000940A1 (ru)
EP (1) EP3233055A1 (ru)
JP (1) JP2017538762A (ru)
KR (1) KR20170099911A (ru)
CN (1) CN107205924A (ru)
AR (1) AR103188A1 (ru)
AU (1) AU2015365533A1 (ru)
BR (1) BR112017012975B1 (ru)
CA (1) CA2969303A1 (ru)
CL (1) CL2017001629A1 (ru)
CO (1) CO2017006268A2 (ru)
CU (1) CU20170088A7 (ru)
DO (1) DOP2017000134A (ru)
EA (1) EA201791409A1 (ru)
EC (1) ECSP17038668A (ru)
IL (1) IL252729A0 (ru)
JO (1) JO3689B1 (ru)
MA (1) MA40599A1 (ru)
MD (1) MD20170071A2 (ru)
MX (1) MX2017008264A (ru)
PE (1) PE20171305A1 (ru)
PH (1) PH12017501005A1 (ru)
SG (1) SG11201704435PA (ru)
TN (1) TN2017000232A1 (ru)
TW (1) TWI649097B (ru)
UA (1) UA122136C2 (ru)
UY (1) UY36466A (ru)
WO (1) WO2016097899A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107229455B (zh) 2016-03-24 2019-09-17 阿里巴巴集团控股有限公司 一种业务处理方法、装置及系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
IT1313579B1 (it) 1999-07-30 2002-09-09 Acraf Composizione farmaceutica liquida a base di paracetamolo.
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
EP1895983A2 (en) * 2005-05-27 2008-03-12 Panacea Biotec Ltd. Injectable compositions and process for preparation of such compositions
PT1973527E (pt) * 2005-12-15 2010-01-04 Acusphere Inc Processos de produção de formulações farmacêuticas à base de partículas destinadas a administração parentérica
AR067048A1 (es) 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
WO2009098716A2 (en) 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
MX2011003695A (es) * 2008-10-09 2011-08-17 A F S P A Aziende Chimiche Riunite Angelini Francesco A C R Formulacion farmaceutica liquida con contenido de paracetamol.
PT2588097T (pt) * 2010-06-30 2021-05-25 Troikaa Pharmaceuticals Ltd Composições farmacêuticas que compreendem paracetamol e processo para preparar as mesmas
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
CN102258485A (zh) * 2011-01-11 2011-11-30 北京润德康医药技术有限公司 一种含对乙酰氨基酚的注射用制剂及其应用
CN102600068A (zh) * 2011-01-24 2012-07-25 联康药业克雷恩特塞提斯制药实验室有限责任公司 稳定即用的可注射扑热息痛制剂

Also Published As

Publication number Publication date
TN2017000232A1 (en) 2018-10-19
KR20170099911A (ko) 2017-09-01
US20180000940A1 (en) 2018-01-04
CN107205924A (zh) 2017-09-26
CL2017001629A1 (es) 2018-03-16
MD20170071A2 (ru) 2017-09-30
UA122136C2 (uk) 2020-09-25
MA40599A1 (fr) 2017-11-30
AU2015365533A1 (en) 2017-07-06
JP2017538762A (ja) 2017-12-28
CU20170088A7 (es) 2018-03-13
EP3233055A1 (en) 2017-10-25
PH12017501005A1 (en) 2017-12-11
AR103188A1 (es) 2017-04-19
CO2017006268A2 (es) 2017-10-20
ECSP17038668A (es) 2017-12-01
PE20171305A1 (es) 2017-09-05
BR112017012975B1 (pt) 2023-09-26
BR112017012975A2 (pt) 2018-02-27
SG11201704435PA (en) 2017-06-29
JO3689B1 (ar) 2020-08-27
CA2969303A1 (en) 2016-06-23
UY36466A (es) 2016-07-29
WO2016097899A1 (en) 2016-06-23
TW201622703A (zh) 2016-07-01
IL252729A0 (en) 2017-08-31
DOP2017000134A (es) 2017-09-15
TWI649097B (zh) 2019-02-01
MX2017008264A (es) 2017-10-02

Similar Documents

Publication Publication Date Title
ZA202102906B (en) Liquid protein formulations containing viscosity-lowering agents
SG10201902915VA (en) Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
HRP20200704T1 (hr) Vodena formulacija koja sadrži paracetamol i ibuprofen
EA201491702A1 (ru) Оптимизированные терапевтические агенты для подкожного введения
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
EA201291433A1 (ru) Содержащие парацетамол фармацевтические композиции и способ их получения
EA201791409A1 (ru) Препараты для инъекций парацетамола
PH12014502494B1 (en) Parenteral esmolol formulation
EA201600331A1 (ru) Фармацевтическая композиция в форме раствора для внутривенного и внутримышечного введения и способ ее получения
RU2013143983A (ru) Способ коррекции иммунной недостаточности у инфицированного вирусом лейкоза крупного рогатого скота
RU2014142874A (ru) Способ лечения похмельного синдрома у лиц, не относящихся к больным алкоголизмом
TH154084A (th) สารละลายอะเซทามิโนเฟนที่ฉีดได้สำหรับการให้ทางไขสันหลัง
GR1008260B (el) Ενδοφλεβιο σκευασμα λινεζολιδης και μεθοδος για την παρασκευη αυτου
TH180780A (th) สารละลายขยายม่านตา และต้านอาการอักเสบที่เสถียร ที่ปลอดจากสารกันบูด สำหรับการฉีด